11例锁骨下动脉瘤腔内介入治疗体会  

Endovascular Interventional Treatment for Subclavian Artery Aneurysms with 11 Cases

作　　者：李学锋[1] 谷涌泉[2] 余恒锡[2] 武欣[1] 焦强[1] 曹娟[1] 

机构地区：[1]中国中医科学院望京医院血管外科,北京100102 [2]首都医科大学宣武医院血管外科,北京100053

出　　处：《现代生物医学进展》2015年第35期6871-6874,共4页Progress in Modern Biomedicine

摘　　要：目的:总结锁骨下动脉瘤腔内介入治疗的经验。方法:11例锁骨下动脉瘤,其中7例真性动脉瘤4例假性动脉瘤,均采用覆膜支架腔内隔绝术进行治疗。结果:本组11例患者腔内介入治疗成功率100%,共置入覆膜支架12枚,无严重并发症发生,均痊愈出院。经平均32.5个月随访,全部患者无明显内漏发生,无动脉瘤复发,除3例患者出现覆膜支架内轻度狭窄(<30%)外,余介入治疗患者的锁骨下动脉血流均通畅。结论:腔内覆膜支架隔绝术治疗锁骨下动脉瘤是一种安全、有效的治疗手段。Objective： To summarize and discuss experiences of endovascular interventional treatment for subclavian artery aneurysms. Methods： 11 cases of subclavian artery aneurysm, including 7 cases of true aneurysm and 4 cases of pseudoaneurysm, using endovascular covered-stent graft implantation for treatment. Results： All 11 patients had underwent endovascular interventional treatment successfully. 12 stents were implanted in all, no serious complications occurred. With an average of 32.5 months＇follow-up, no patients occurred the endoleak. No recurrence of aneurysm. Mild stenosis （〈 30%） occurred only in 3 cases, the other patients had maintained the unobstructed subclavian artery. Conclusions： Endovascular covered-stent graft implantation is a safe and effective method for treating the subclavian artery aneurysm.

关 键 词：锁骨下动脉瘤 腔内介入治疗 覆膜支架 

分 类 号：R732.21[医药卫生—肿瘤]